Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 23, Pages 15987-16005
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-17
DOI
10.1074/jbc.m113.532804
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA
- (2014) Huei-Jiun Li et al. ACS Chemical Biology
- Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme–Product Complex
- (2013) Andrew Chang et al. BIOCHEMISTRY
- Resistance to AFN-1252 Arises from Missense Mutations inStaphylococcus aureusEnoyl-acyl Carrier Protein Reductase (FabI)
- (2013) Jiangwei Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mode of Action,In VitroActivity, andIn VivoEfficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
- (2012) Nachum Kaplan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- XDSAPP: a graphical user interface for the convenient processing of diffraction data usingXDS
- (2012) Michael Krug et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- From Triclosan toward the Clinic: Discovery of Nonbiocidal, Potent FabI Inhibitors for the Treatment of Resistant Bacteria
- (2012) Vincent Gerusz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin
- (2012) Uwe Mueller et al. JOURNAL OF SYNCHROTRON RADIATION
- Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality
- (2012) Johannes Schiebel et al. STRUCTURE
- The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound
- (2011) S. Escaich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- fconv: format conversion, manipulation and feature computation of molecular data
- (2011) G. Neudert et al. BIOINFORMATICS
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei
- (2011) N. Liu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- DSX: A Knowledge-Based Scoring Function for the Assessment of Protein–Ligand Complexes
- (2011) Gerd Neudert et al. Journal of Chemical Information and Modeling
- Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors
- (2011) J. B. Parsons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Mechanism and Inhibition of the FabV Enoyl-ACP Reductase fromBurkholderia mallei
- (2010) Hao Lu et al. BIOCHEMISTRY
- A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase fromMycobacterium tuberculosis
- (2010) Sylvia R. Luckner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Medicinal Chemist’s Guide to Molecular Interactions
- (2010) Caterina Bissantz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Essentiality of FASII pathway for Staphylococcus aureus
- (2010) Wendy Balemans et al. NATURE
- Slow-Onset Inhibition of the FabI Enoyl Reductase fromFrancisella tularensis: Residence Time andin VivoActivity
- (2009) Hao Lu et al. ACS Chemical Biology
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- What is MRSA?
- (2009) A. Pantosti et al. EUROPEAN RESPIRATORY JOURNAL
- Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
- (2009) Sophie Brinster et al. NATURE
- Structural insights intoStaphylococcus aureusenoyl-ACP reductase (FabI), in complex with NADP and triclosan
- (2009) Amit Priyadarshi et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
- (2008) Hao Lu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Mechanism and Inhibition of saFabI, the Enoyl Reductase fromStaphylococcus aureus†
- (2008) Hua Xu et al. BIOCHEMISTRY
- Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase
- (2008) Suresh K. Tipparaju et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
- Small Molecule Conformational Preferences Derived from Crystal Structure Data. A Medicinal Chemistry Focused Analysis
- (2008) Ken A. Brameld et al. Journal of Chemical Information and Modeling
- Accurate Structural Correlations from Maximum Likelihood Superpositions
- (2008) Douglas L. Theobald et al. PLoS Computational Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search